JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, vol.26, no.4, pp.553-559, 2007 (SCI-Expanded)
To evaluate the predictability of urine calcium (Ca2+) and deoxypyridinoline (DPD) in the assessment of response to palliative radiation therapy (RT) for metastatic bone disease.